Navigation Links
Seniors Can Be Heartened by New Study on Statins

Groundbreaking Research Finds Statins Cut Risk of Heart Attacks, Deaths

RESTON, Va., Nov. 13 /PRNewswire-USNewswire/ -- Cardiovascular Disease is the leading cause of death among Americans, costing our healthcare system hundreds of millions of dollars and causing untold suffering. Now there is new hope for preventing this fatal disease - even among those who weren't thought to be at risk.

A new study has found that millions of people could cut their risk of a heart attack, stroke and death by taking statins. The study, released at the American Medical Association's annual meeting this week, found the benefits even for people with low cholesterol and no major risk for heart disease.

"This is the kind of news that could really save lives," said Michelle Plasari, President of RetireSafe's Senior Center for Health and Security. "According to this study, even people who believe they are at low risk for a heart attack could benefit from taking statins. This could transform the way we prevent heart disease."

About half all heart attacks and strokes occur in people who do not have elevated cholesterol. This study showed that a daily dose of a statin called rosuvastatin can prevent heart attacks and deaths in that group - people who would not normally be treated for heart disease.

Patients in the study had normal cholesterol. But they had higher levels of C-reactive protein, a marker of inflammation that indicates a risk of heart disease.

"This study shows that even if you have low cholesterol levels, you aren't safe from heart disease," Plasari said.

According to the American Heart Association, Americans over the age of 65 are at the highest risk of developing heart disease. At this age, initial heart attacks tend to be more fatal than those suffered at a younger age.

The first step to protecting yourself from heart disease is maintaining a healthy lifestyle. This can include a balanced diet, weight loss, exercise, smoking cessation, and limiting the amount of alcohol consumed.

"This study shows statins could be one more way to protect yourself from heart disease," Plasari said.

Statins are a class of prescription drugs that lower the level of cholesterol in the blood by reducing the production of cholesterol by the liver. Combined with diet and exercise, statins are estimated to lower blood cholesterol levels by as much as 40 to 60 percent.

Statins have not only been clinically-proven to lower cholesterol and reduce the risk of heart disease, they have been linked to lowering the risk of dying from emphysema, chronic bronchitis, influenza, and pneumonia.

To learn more about atherosclerosis and heart disease, visit .

SOURCE RetireSafe
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
2. Soft Contact Lenses Do Not Lead to Myopic Creep in Children, Study Shows
3. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
4. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
5. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
6. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
7. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
8. CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
9. Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
10. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
11. Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds
Post Your Comments:
(Date:12/1/2015)... 1, 2015   MabVax Therapeutics Holdings, Inc . ... it has filed an Investigational New Drug Application (IND) ... the Company,s lead fully human antibody product HuMab 5B1 ... plans to initiate the Phase I clinical trial early ... --> The planned Phase I trial will evaluate ...
(Date:12/1/2015)... , Dec. 1, 2015   Craneware, Inc ... cycle solutions, today announced the company will showcase ... ChargeLink ® solution at the American ... Clinical Meeting . The new features are focused ... of monitoring and managing enterprise-wide pharmacy charges to ...
(Date:12/1/2015)... , Dec. 01, 2015 ... of the "Medical Alert Systems/Personal Emergency Response ... by Geography - Global Forecas" report to ... announced the addition of the "Medical Alert ... by End-User and by Geography - Global Forecas" ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... The Multiple System Atrophy Coalition has announced the launch of ... (MSA) research, timed today to coincide with Giving Tuesday 2015, a global day of ... to work and be productive, to do simple daily activities like walking to the ...
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, ... expansion of the company’s growing product line of food safety and seafood fraud ... Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
Breaking Medicine News(10 mins):